Background
Severe primary graft dysfunction (PGD) is a major cause of early morbidity and mortality in patients after lung transplantation. The etiology and pathophysiology of PGD is not fully characterized and whether intraoperative fluid administration increases the risk for PGD remains unclear from previous studies. We therefore tested the hypothesis that increased total intraoperative fluid volume during lung transplantation is associated with the development of grade-3 PGD.
Methods
This retrospective cohort analysis included patients who had lung transplantation at the Cleveland Clinic between January 2009 and June 2013. We used multivariable logistical regression with adjustment for donor, recipient, and perioperative confounding factors to examine the association between total intraoperative fluid administration and development of grade-3 PGD in the initial 72 postoperative hours. Secondary outcomes included time to initial extubation and intensive care unit length of stay.
Results
Grade-3 PGD occurred in 123 of 494 patients (25%) who had lung transplantation. Patients with grade-3 PGD received a larger volume of intraoperative fluid (median 5.0 [3.8, 7.5] L) than those without grade-3 PGD (3.9 [2.8, 5.2] L). Each intraoperative liter of fluid increased the odds of grade-3 PGD by approximately 22% (adjusted odds ratio [95%CI] of 1.22 (1.12,1.34), P <0.001). The volume of transfused red blood cell concentrate was associated with grade-3 PGD (1.1 [0.0, 1.8] L for PGD-3 versus 0.4 [0.0, 1.1 for non-grade-3 PGD] L; adjusted OR CI 95% 1.7 (1.08, 2.7); P = 0.002). Increased fluid administration was associated with longer intensive care unit stay (adjusted hazard ratio (97.5% CI): 0.92 [0.88, 0.97], P < 0.001), but not time to initial tracheal extubation (hazard ratio [97.5% CI]: 0.97[0.93,1.02], P =0.17).
Conclusions
Increased intraoperative fluid volume is associated with the most severe form of PGD after lung transplant surgery. Limiting fluid administration may reduce the risk for development of grade-3 PGD and thus improve early postoperative morbidity and mortality after lung transplantation.